There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...

According to a new report by the US National Security Commission on Emerging Biotechnology, China’s systematic state-driven ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

China has pulled ahead of the United States in key areas of the life sciences, and the U.S. may only have a handful of years ...

A potential U.S. launch of this Chinese biotech's new lung cancer drug - which bested Merck's blockbuster Keytruda - is a key ...

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

Charles River initially unveiled a plan to adopt new alternative methods (NAMs), like computer models and human organoids, in ...

The commission also says Congress should prohibit companies working with national security agencies and the Department of Health and Human Services from using some Chinese biotech suppliers deemed ...

China is moving fast to dominate biotechnology, and the U.S. risks ... in the U.S., while barring companies from working with Chinese biotech suppliers, the National Security Commission on ...

The severe ESG risk rating is consistent with Chinese biotech company ratings on Sustainalytics. The risks are primarily from product governance and regulatory uncertainties. We assign Innovent an ...

The China Biotechnology Directory 2025 is an indispensable resource for navigating the fast-growing Chinese biotech market. With thousands of up-to-date company profiles, executive contacts, and ...